Received Oct 21, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | 1 | Y015760 | OT |
No additional AE; GARDASIL-9 was administered to a patient after the excursion.; This spontaneous report was received from an other health professional and refers to a patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 22-Sep-2025, the patient was vaccinated with an improper stored vaccine of Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9), Suspension for injection (lot #Y015760, expiration date: 10-Feb-2027), dose number 1, 0.5 mL, total, administered by Intramuscular route.as prophylaxis (Product storage error). The improperly stored vaccine underwent a temperature excursion of 47.7 degrees Fahrenheit (F) for 12 minutes with of 46.8 F for 5 minutes; 47.1 F for 9 minutes; and 46.6 F for 4 minutes. No adverse events were reported. This is one of several reports received from the same reporter.